These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26935441)

  • 1. Comprehensive Health-Related Quality of Life is Influenced by Nocturia and Sleep Disturbance: Investigation Based on the SF-8.
    Suekane S; Ueda K; Suyama S; Hayashi T; Toyozawa N; Yoshitake M; Nishihara K; Sakashita N; Uchimura N; Matsuoka K
    Kurume Med J; 2016; 62(1-2):9-16. PubMed ID: 26935441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of imidafenacin on nocturia and sleep disorder in patients with overactive bladder.
    Wada N; Watanabe M; Kita M; Matsumoto S; Osanai H; Yamaguchi S; Numata A; Fujisawa M; Saga Y; Hou K; Iuchi H; Niibori D; Kura T; Taniguchi A; Kunieda M; Nakata Y; Kakizaki H
    Urol Int; 2012; 89(2):215-21. PubMed ID: 22832092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.
    Kido K; Hatakeyama S; Imai A; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Nakaji S; Ohyama C
    Eur Urol Focus; 2019 Nov; 5(6):1120-1126. PubMed ID: 29735367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of imidafenacin in patients with over active bladder, nocturia, or sleep disorders (Sayama-Iruma-Hannou study)].
    Suzuki T; Uwatoko N; Watanabe A; Miyata K
    Hinyokika Kiyo; 2013 Jun; 59(6):335-40. PubMed ID: 23827864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does successful treatment of overactive bladder improve co-morbidities in patients with nocturia?
    Chin KS; Rose GE; Ervin CF; Ong TJ; Whishaw DM; Bower WF
    Australas J Ageing; 2019 Dec; 38(4):242-248. PubMed ID: 30865375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
    Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
    Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Daytime or Nighttime Dosing with Solifenacin for Overactive Bladder with Nocturia: Impact on Nocturia and Sleep Quality.
    Kwon T; Oh TH; Choi S; Cho WY; Min K; Lee JZ; Moon KH
    J Korean Med Sci; 2017 Sep; 32(9):1491-1495. PubMed ID: 28776345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance.
    Takao T; Tsujimura A; Yamamoto K; Fukuhara S; Nakayama J; Matsuoka Y; Miyagawa Y; Nonomura N
    Urology; 2011 Sep; 78(3):648-52. PubMed ID: 21676440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mediating role of sleep quality in the association between nocturia and health-related quality of life.
    Choi EPH; Wan EYF; Kwok JYY; Chin WY; Lam CLK
    Health Qual Life Outcomes; 2019 Dec; 17(1):181. PubMed ID: 31829192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urgency, frequency, and nocturia in defining overactive bladder adaptive behavior.
    Minassian V; Stewart W; Hirsch A; Kolodner K; Fitzgerald M; Burgio K; Cundiff G; Blaivas J; Newman D; Dilley A
    Neurourol Urodyn; 2011 Mar; 30(3):406-11. PubMed ID: 21412822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].
    Shimada M; Inoue K; Okumura T; Aoki S; Ogawa Y; Matsubara E; Maeda T; Ogawa Y; Sasaki H
    Hinyokika Kiyo; 2011 Jan; 57(1):1-6. PubMed ID: 21304252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).
    Yamaguchi O; Kakizaki H; Homma Y; Igawa Y; Takeda M; Nishizawa O; Gotoh M; Yoshida M; Yokoyama O; Seki N; Okitsu A; Hamada T; Kobayashi A; Kuroishi K
    BJU Int; 2015 Oct; 116(4):612-22. PubMed ID: 25639296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
    Konishi S; Hatakeyama S; Imai A; Kumagai M; Okita K; Togashi K; Hamaya T; Hamano I; Okamoto T; Iwamura H; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
    Low Urin Tract Symptoms; 2021 Jan; 13(1):56-63. PubMed ID: 32496639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of overactive bladder symptom on quality of life in stroke patients.
    Itoh Y; Yamada S; Konoeda F; Koizumi K; Nagata H; Oya M; Suzuki N
    Neurourol Urodyn; 2013 Jun; 32(5):428-34. PubMed ID: 23129306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.